Expansion of our global clinical services network continues to California PCI Pharma Services is pleased to announce the completion of our acquisition of Sherpa Clinical Packaging (Sherpa). Located in San Diego, Sherpa is a recognized provider of Clinical Trial materials management services and is known for its high quality, flexibility, and speed-to-market in support of […]
In scavenging for undesired moisture and gases, protective packaging solution enables enhanced shelf life and speed-to-market for pharmaceutical and medical device products. PCI Pharma Services is pleased to announce an exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for […]
PCI Expands Clinical Services’ presence with acquisition of California-based Sherpa Clinical Packaging Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a […]
Welsh Secretary to visit pharmaceutical giant PCI Pharma Services in Bridgend following the publication of the UK-EU Future Relationship White Paper Alun Cairns: “The UK Government will carry out its duty to protect Welsh industries as we leave the EU“ Welsh Secretary Alun Cairns will continue his effort to provide reassurance to key business sectors […]
Purpose-built state-of-the-art Cold Chain facility opens in Rockford, IL PCI is pleased to announce the completion of a purpose built -40°C storage and distribution facility at our North American Clinical Services Center of Excellence. The site, located in Rockford, IL, features packaging and labeling services, logistical services for global storage and distribution, as well as […]
Bill Mitchell to Assume Role of Executive Co-Chairman PCI Pharma Services today announced that Salim Haffar will join the Company as Chief Executive Officer later this year. Mr. Haffar, who has resigned as President of AptarGroup’s Aptar Pharma, effective September 1, 2018, will succeed Bill Mitchell, who will step out of his role as President […]
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Your bridge between life-changing therapies and patients